As explored in part one of this article series, it is well documented that the microbiome of research models can have a profound effect on experimental reproducibilit...

Ultimately, it is people that determine whether a major transformation project will deliver the hoped-for results, and it is unrealistic to expect everyone to get beh...

Nuclear molecular imaging is a popular research tool across multiple preclinical applications including oncology, neurology, and cardiology. Todd Sasser at Bruker Bio...

Understanding how cells make choices is one of the great challenges in biology. Whether it is the first cell divisions of embryonic development or activation in respo...

For several years, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has been making waves in the scientific community. Its ability to pre...

Although antibodies, at the time of writing, still dominate the clinic, there is a definite shift in the drug development pipeline towards more “complex”, next-genera...

While Zika is no longer in the public eye, it hasn’t vanished. Recent outbreaks across Asia and Africa are reminders that Zika is alive and well, and with no effectiv...

Vaccination represents, together with the supply of fresh water, the most efficient tool to prevent infectious diseases in human. Vaccines` power is undeniable, ever ...

Biotherapeutic production relies on robust cell lines with reproducible growth, titre and quality, so determining the titre of biopharmaceuticals at multiple points d...

The digital transformation of the pharmaceutical industry has been slow and is far from complete. This unique transformation started with basic video content in the e...